We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Oxytocin
A nine-amino-acid hormone with two very different stories. As an IV drug (Pitocin/Syntocinon) it is an established, supervised hospital medicine for inducing/augmenting labor and controlling postpartum bleeding. As a grey-market intranasal 'love/bonding/trust' spray it is largely UNPROVEN — the largest, most rigorous autism RCT (Sikich 2021, NEJM) was negative on its primary outcome, and replication of the famous single-dose social effects has been poor.
Prescription medication — not a dietary supplement
Oxytocin is a prescription (or investigational) drug, not a supplement. It is included here for reference because people research and discuss it (often used off-label) — not as a recommendation. Take it only under a qualified clinician's supervision and only as prescribed; do not source it from grey-market vendors, where identity, purity, and dosing are unverified. The evidence below reflects its clinical trials.
What the evidence says
Most Oxytocin studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1972–2026 with a typical study size of 445 participants.
Based on 986 studies · 78 meta-analyses · 861 RCTs · 445 total participants
Confidence
High confidenceBy outcome
The popular intranasal social use scores low because the largest RCT (Sikich 2021, NEJM, n=290) was null and meta-analyses are mixed-to-weak; only supervised IV obstetric use is well-established.
1,022 rigorous studies
879 randomized trials · 91 meta-analyses · 113 systematic reviews
Our evidence rating for Oxytocin is accountable to this entire body of rigorous research indexed in PubMed — not a hand-picked subset.
PubMed · as of Jul 2026
123 trials ongoing or recruiting · 549 completed on ClinicalTrials.gov
141 of the completed trials have posted results
Registered trials show research momentum for Oxytocin, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Aug 2026
Oxytocin is a hypothalamic neuropeptide that acts both as a circulating hormone and as a central neuromodulator. The honest evidence picture splits sharply by use.
(1) Medical/obstetric use: intravenous oxytocin (Pitocin, Syntocinon) is a long-established, FDA-approved drug given under continuous monitoring to induce or augment labor and to prevent/treat postpartum haemorrhage via uterine contraction; it also drives the milk-ejection (let-down) reflex in lactation.
This use is real and supervised, but it is a hospital intervention with risks (uterine hyperstimulation, fetal heart-rate changes, rare uterine rupture, water intoxication/hyponatraemia from antidiuretic activity) — not something to self-administer.
(2) Intranasal behavioural/psychiatric use: after early single-dose studies suggested oxytocin nasal spray could increase trust (Kosfeld 2005, Nature) and social cognition, it was widely hyped as a 'love hormone' and marketed grey-market for bonding, social anxiety, and autism.
The rigorous follow-up has been largely disappointing. The landmark phase-2 NIH multisite RCT in 290 autistic children and adolescents (Sikich 2021, NEJM, 24 weeks) found NO significant benefit on its primary social-withdrawal outcome versus placebo.
Meta-analyses of repeated intranasal oxytocin in autism and schizophrenia are mixed-to-null: some report a small effect on isolated social-cognition sub-measures, but overall core-symptom benefit is weak, inconsistent, and not robust to publication bias and trial quality. Brain-imaging trust studies (e.g.
Baumgartner 2008) are mechanistically interesting but small. The overall evidence for the popular intranasal social/behavioural use is therefore emerging at best and substantially over-sold relative to the data.
Binds the oxytocin receptor (OXTR), a G-protein-coupled receptor. In the periphery this triggers uterine smooth-muscle contraction and mammary myoepithelial contraction (milk ejection); in the brain (amygdala, striatum, hypothalamus) it modulates social-salience and threat-processing circuits.
Intranasal oxytocin is proposed to dampen amygdala threat reactivity and bias attention toward social cues. fMRI work links it to reduced amygdala/midbrain activation during trust adaptation — but behavioural translation in patient RCTs has been weak.
The well-established peripheral action: dose-dependent uterine contraction (labor induction/augmentation, postpartum haemostasis) and triggering of the milk-ejection reflex during lactation.
How Oxytocin works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
IV oxytocin is used IN labor under continuous medical supervision — never self-administer. Do not use intranasal/grey-market oxytocin in pregnancy.
The largest, most rigorous RCT was negative; do not expect benefit from grey-market intranasal oxytocin. Discuss any interest with a clinician.
Oxytocin can affect blood pressure and sodium balance — medical use requires monitoring.
Severe hypertension has been reported when oxytocin is given with vasopressors; relevant to the medical IV setting.
Combined uterotonic use can cause uterine hyperstimulation — managed by clinicians in the obstetric setting.
Oxytocin's antidiuretic activity plus excess electrolyte-free fluid can cause water intoxication and hyponatraemia.
Tip: Clinician titration and continuous monitoring; reduce/stop infusion
Tip: Limit electrolyte-free fluids; monitor sodium
Tip: Reported with intranasal use; reduce/stop
Tip: Poorly characterised with intranasal use; discontinue if troublesome
Oxytocin has an evidence score of 4/10 — emerging evidence based on 935 indexed studies, including 6 meta-analyses. A nine-amino-acid hormone with two very different stories. As an IV drug (Pitocin/Syntocinon) it is an established, supervised hospital medicine for inducing/augmenting labor and controlling postpartum bleeding. As a grey-market intranasal 'love/bonding/trust' spray it is largely UNPROVEN — the largest, most rigorous autism RCT (Sikich 2021, NEJM) was negative on its primary outcome, and replication of the famous single-dose social effects has been poor. Representative study: PMID 31032882.
The commonly studied dose of Oxytocin is No legitimate consumer dose. Medical IV oxytocin is titrated by clinicians under monitoring; intranasal doses used in research trials are typically 18-48 IU/day, but this use is investigational and not endorsed for self-administration.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Oxytocin — consistent daily use matters more than the time of day. Research trials administer intranasal oxytocin once or twice daily (e.g.
Oxytocin should be used with caution — talk to a healthcare provider before taking it. The most commonly reported side effects are uterine hyperstimulation / tachysystole (IV use), hyponatraemia / water intoxication (high-dose IV), headache / nausea. Use caution if any of these apply to you: Self-administration in pregnancy outside clinical supervision; Use of medical IV oxytocin except in a monitored hospital setting; Known hypersensitivity to oxytocin.
Omega-3
Probably helpsEssential fatty acids critical for brain health, mood regulation, and reducing inflammation throughout the body.
Magnesium
Likely helpsSupports 300+ enzymatic reactions — critical for sleep, stress response, muscle function, and cognitive health.
St. John's Wort
Mixed evidenceModulates serotonin, dopamine, and norepinephrine; studied for mood, with trials in mild-to-moderate depression comparing it to SSRIs — requires drug-interaction caution.
Ashwagandha
Likely helpsReduces cortisol and anxiety while improving sleep quality and physical recovery in stressed adults.
Explore: Best supplements for Focus, Memory & Mood
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 990 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research